Skip to main content

Articles

459 result(s) for 'alliance clinical trials' within Trials

Page 1 of 10

  1. Alliance for Clinical Trials in Oncology (Alliance) coordinated trials utilize Medidata Rave® (Rave) as the primary clinical data capture system. A growing number of ... and complex cancer care delivery research ...

    Authors: David Zahrieh, Shauna L. Hillman, Angelina D. Tan, Jennifer L. Frank, Travis Dockter, Bobbi Jo Meyers, Cassie L. Cherevko, Elizabeth S. Peil, Shaylene McCue, Oudom Kour, Heather J. Gunn, Heather B. Neuman, George J. Chang, Electra D. Paskett, Sumithra J. Mandrekar and Amylou C. Dueck
    Citation: Trials 2022 23:645
  2. Despite the problem of inadequate recruitment to randomised trials, there is little evidence to guide researchers on decisions about how people are effectively recruited to take part in trials. The PRioRiTy st...

    Authors: Patricia Healy, Sandra Galvin, Paula R. Williamson, Shaun Treweek, Caroline Whiting, Beccy Maeso, Christopher Bray, Peter Brocklehurst, Mary Clarke Moloney, Abdel Douiri, Carrol Gamble, Heidi R. Gardner, Derick Mitchell, Derek Stewart, Joan Jordan, Martin O’Donnell…
    Citation: Trials 2018 19:147

    The Commentary to this article has been published in Trials 2018 19:584

  3. The Alliance for Clinical Trials in Oncology (Alliance) trial A191901 is an ongoing, four-arm ( ... plus MI, or enhanced usual care) randomized clinical trial that tests the efficacy and effect of ... the Pillsy ...

    Authors: Joannie Ivory, Stephanie B. Wheeler, Sarah Drier, Heather Gunn, David Zahrieh, Electra Paskett, Michelle Naughton, Rachel Wills, Kayla Swetel, Selina Chow and Katherine Reeder-Hayes
    Citation: Trials 2023 24:664
  4. One of the top three research priorities for the UK clinical trial community is to address the gap in evidence-based approaches to improving participant retention in randomised trials. Despite this, there is l...

    Authors: Dan Brunsdon, Linda Biesty, Peter Brocklehurst, Valerie Brueton, Declan Devane, Jim Elliott, Sandra Galvin, Carrol Gamble, Heidi Gardner, Patricia Healy, Kerenza Hood, Joan Jordan, Doris Lanz, Beccy Maeso, Amanda Roberts, Imogen Skene…
    Citation: Trials 2019 20:593
  5. Acute myeloid leukemia (AML) is the most common acute leukemia in adults and has an unacceptably low cure rate. In recent years, a number of new treatment strategies and compounds were developed for the treatment...

    Authors: Katharina M. Lang, Kathryn L. Harrison, Paula R. Williamson, Brian J. P. Huntly, Gert Ossenkoppele, Jan Geissler, Tamàs Bereczky, Jesús M. Hernández-Rivas, Hélène Chevrou-Séverac, Rory Goodbody, Renate Schulze-Rath and Lars Bullinger
    Citation: Trials 2020 21:437
  6. This study will implement a multilevel intervention with patient and clinician components as a NCORP Cancer Care Delivery Research (CCDR) trial within the Alliance for Clinical Trials in Oncology Research Base (Alliance

    Authors: Sarah T. Hawley, Kelley Kidwell, David Zahrieh, Anne McCarthy, Rachel Wills, Aaron Rankin, Timothy Hofer, Selina Chow, Reshma Jagsi and Heather Neuman
    Citation: Trials 2023 24:16
  7. The stratified model of care has been an effective approach for the treatment of low back pain. However, the treatment of patients with low risk of psychosocial-factor involvement is unclear. The addition of t...

    Authors: Felipe Ribeiro Cabral Fagundes, Caique de Melo do Espírito Santo, Francine Mendonça de Luna Teixeira, Thaís Vanelli Tonini and Cristina Maria Nunes Cabral
    Citation: Trials 2017 18:49
  8. Motivation and a therapeutic alliance are crucial for successful therapy. It is assumed that dogs can increase motivation and help support therapeutic relationships. This is one of the reasons for including do...

    Authors: Wanda Arnskötter, Suzanne Martin, Susanne Walitza and Karin Hediger
    Citation: Trials 2024 25:26
  9. Prioritisation of clinical trials ensures that the research conducted meets the needs of stakeholders, makes the best use of resources and avoids duplication. The aim of this review was to identify and critica...

    Authors: Rachael L. Morton, Haitham Tuffaha, Vendula Blaya-Novakova, Jenean Spencer, Carmel M. Hawley, Phil Peyton, Alisa Higgins, Julie Marsh, William J. Taylor, Sue Huckson, Amy Sillett, Kieran Schneemann, Anitha Balagurunanthan, Miranda Cumpston, Paul A. Scuffham, Paul Glasziou…
    Citation: Trials 2022 23:1000
  10. Couple relationship distress is common and associated with poor physical, psychological, and relational outcomes for both partners. Emotionally Focused Therapy for couples (EFT) is a short-term structured appr...

    Authors: Martiño Rodríguez-Gonzalez, Shayne Anderson, Alfonso Osorio, Marie-France Lafontaine, Paul S. Greenman, María Calatrava, Dania Andrade, Ragan Lybbert, Pilar Martínez-Diaz, Patrick Steffen, Jokin de Irala and Jonathan Sandberg
    Citation: Trials 2022 23:891
  11. The translation of evidence from clinical trials into practice is complex. One approach to ... translation is to consider the ‘implementability’ of trials as they are designed and conducted. Implementability of trials

    Authors: Miranda S. Cumpston, Steven A. Webb, Philippa Middleton, Greg Sharplin and Sally Green
    Citation: Trials 2021 22:232
  12. Clinical trial evidence underpins evidence-based medicine and the improvement of healthcare worldwide. In Australasia, a significant proportion of clinical trials are conducted by geographically dispersed and ...

    Authors: Megan Sanders, Karen Goulding, Ed Oakley, Donna Reidlinger and Katie M Groom
    Citation: Trials 2023 24:707
  13. Cognitive behavioural therapy (CBT) has been found to be effective in reducing fatigue severity in MS patients directly following treatment. However, long-term effects are inconsistent leaving room for improve...

    Authors: Marieke Houniet-de Gier, Heleen Beckerman, Kimberley van Vliet, Hans Knoop and Vincent de Groot
    Citation: Trials 2020 21:98
  14. The improvement of psychological treatments for depression in young adults is a pressing issue highlighted in the literature. Its relevance is determined not only because young adults are underrepresented in r...

    Authors: Adrián Montesano, Joan C. Medina, Clara Paz, Helena García-Mieres, Noelia Niño-Robles, Eugeni García-Grau, Josep Cañete Crespillo, Alejandro García-Gutiérrez, Miquel Alabèrnia-Segura and Guillem Feixas
    Citation: Trials 2021 22:916
  15. The IREM-Freq trial is an international multicenter randomized clinical trial conducted in mental healthcare centers across Australia, ... . Process measures include memory, learning, therapeutic alliance, motiva...

    Authors: Carlijn J. M. Wibbelink, Christopher W. Lee, Nathan Bachrach, Sarah K. Dominguez, Thomas Ehring, Saskia M. van Es, Eva Fassbinder, Sandra Köhne, Magda Mascini, Marie-Louise Meewisse, Simone Menninga, Nexhmedin Morina, Sophie A. Rameckers, Kathleen Thomaes, Carla J. Walton, Ingrid G. Wigard…
    Citation: Trials 2021 22:848
  16. Clinical Trial Networks in which trialists work collaboratively enable multi-site, large-scale, high-quality clinical trials to be efficiently run. Although the benefits of Clinical Trial Networks are largely kno...

    Authors: Fiona Nemeh, Rachelle Buchbinder, Carmel M. Hawley, Mark R. Nelson, Jacqui G. Waterkeyn and Christopher M. Reid
    Citation: Trials 2022 23:81
  17. The investigation of mindfulness-based interventions (MBIs) in cognitive-behavioral therapy has greatly increased over the past years. However, most MBI research with youth focuses on structured, manualized gr...

    Authors: Julia Kalmar, Ines Baumann, Elena Gruber, Eva Vonderlin, Hinrich Bents, Andreas B. Neubauer, Thomas Heidenreich and Johannes Mander
    Citation: Trials 2022 23:291
  18. Continuous feedback on patient improvement and the therapeutic alliance may reduce the number of dropouts and ... There are, however, only three published randomized trials on the effect of feedback on the ... in...

    Authors: Annika Helgadóttir Davidsen, Stig Poulsen, Mette Waaddegaard, Jane Lindschou and Marianne Lau
    Citation: Trials 2014 15:138
  19. Growing use of cloud computing in clinical trials prompted the European Clinical Research Infrastructures Network, a European non-profit organisation established to support multinational clinical research, to ...

    Authors: Christian Ohmann, Steve Canham, Edgar Danielyan, Steve Robertshaw, Yannick Legré, Luca Clivio and Jacques Demotes
    Citation: Trials 2015 16:318
  20. We assessed the prevalence, and potential impact of, trials of pharmacological agents for acute stroke that were completed but not published in full. Failure to publish trial data is to be deprecated as it set...

    Authors: Lorna M Gibson, Miriam Brazzelli, Brenda M Thomas and Peter AG Sandercock
    Citation: Trials 2010 11:43
  21. Major depressive disorder (MDD) is a leading cause of disease morbidity. Combined treatment with antidepressant medication (ADM) plus psychotherapy yields a much higher MDD remission rate than ADM only. But 77...

    Authors: Robert M. Bossarte, Ronald C. Kessler, Andrew A. Nierenberg, Ambarish Chattopadhyay, Pim Cuijpers, Angel Enrique, Phyllis M. Foxworth, Sarah M. Gildea, Bea Herbeck Belnap, Marc W. Haut, Kari B. Law, William D. Lewis, Howard Liu, Alexander R. Luedtke, Wilfred R. Pigeon, Larry A. Rhodes…
    Citation: Trials 2022 23:520
  22. Evidence generated from partnering with parents to design and conduct research together may be used to refine, adjust, and modify future research approaches. This study aimed to describe the initial approaches...

    Authors: Leigh M. Vanderloo, Shelley M. Vanderhout, Erika Tavares, Jonathon Maguire, Sharon Straus and Catherine S. Birken
    Citation: Trials 2021 22:347
  23. New considerations during the ethical review processes may emerge from innovative, yet unfamiliar operational methods enabled in pragmatic randomized controlled trials (RCT), potentially making institutional r...

    Authors: Guillaume Marquis-Gravel, Holly Robertson, W. Schuyler Jones, Danielle Riley, Daniel E. Ford, David Crenshaw, Yvonne A. Joosten, Lindsey Rudov, Adrian F. Hernandez and Rachel Hess
    Citation: Trials 2021 22:90
  24. People with psychosis have high rates of trauma, with a post-traumatic stress disorder (PTSD) prevalence rate of approximately 15%, which exacerbates psychotic symptoms such as delusions and hallucinations. Pi...

    Authors: Emmanuelle Peters, Amy Hardy, Robert Dudley, Filippo Varese, Kathryn Greenwood, Craig Steel, Richard Emsley, Nadine Keen, Samantha Bowe, Sarah Swan, Raphael Underwood, Eleanor Longden, Sarah Byford, Laura Potts, Margaret Heslin, Nick Grey…
    Citation: Trials 2022 23:429
  25. Interventional clinical studies conducted in the regulated drug research environment are designed using International Council for Harmonisation (ICH) regulatory guidance documents: ICH E6 (R2) Good Clinical Pr...

    Authors: Madhavi Gidh-Jain, Tom Parke, Franz König, Cecile Spiertz and Peter Mesenbrink
    Citation: Trials 2024 25:204
  26. Poor recruitment to, and retention in, clinical trials is a source of research waste that could be reduced by more informed choices about participation. Barriers to effective recruitment and retention can be w...

    Authors: Katie Gillies, Iain Chalmers, Paul Glasziou, Diana Elbourne, Jim Elliott and Shaun Treweek
    Citation: Trials 2019 20:613
  27. Routinely collected electronic health records (EHRs) have the potential to enhance randomised controlled trials (RCTs) by facilitating recruitment and follow-up. Despite this, current EHR use is minimal in UK ...

    Authors: Archie Macnair, Sharon B. Love, Macey L. Murray, Duncan C. Gilbert, Mahesh K. B. Parmar, Tom Denwood, James Carpenter, Matthew R. Sydes, Ruth E. Langley and Fay H. Cafferty
    Citation: Trials 2021 22:340
  28. Given the complex nature of opioid addiction treatment and the rising number of available opioid substitution and antagonist therapies (OSAT), there is no ‘gold standard’ measure of treatment effectiveness, an...

    Authors: Brittany B. Dennis, Nitika Sanger, Monica Bawor, Leen Naji, Carolyn Plater, Andrew Worster, Julia Woo, Anuja Bhalerao, Natasha Baptist-Mohseni, Alannah Hillmer, Danielle Rice, Kim Corace, Brian Hutton, Peter Tugwell, Lehana Thabane and Zainab Samaan
    Citation: Trials 2020 21:30
  29. Hundreds of youth psychotherapy randomized trials have generated scores of helpful empirically supported treatments (ESTs). However, the standardized structure of many ESTs and their focus on a single disorder...

    Authors: Abby Bailin, Evelyn Cho, Ariel Sternberg, Spencer C. Evans, Nathan L. Hollinsaid, Sarah Kate Bearman and John R. Weisz
    Citation: Trials 2023 24:682
  30. Impairment in social functioning is a key component of personality disorder. Therefore psycho-education and problem solving (PEPS) therapy may benefit people with this disorder. Psycho-education aims to educat...

    Authors: Mary McMurran, Mike J Crawford, Joseph G Reilly, Paul McCrone, Paul Moran, Hywel Williams, Clive E Adams, Conor Duggan, Juan Delport, Diane Whitham and Florence Day
    Citation: Trials 2011 12:198
  31. It has been demonstrated that cognitive behavioural therapy (CBT) has a moderate effect on symptom reduction and on general well being of patients suffering from psychosis. However, questions regarding the spe...

    Authors: Stefan Klingberg, Andreas Wittorf, Christoph Meisner, Wolfgang Wölwer, Georg Wiedemann, Jutta Herrlich, Andreas Bechdolf, Bernhard W Müller, Gudrun Sartory, Michael Wagner, Tilo Kircher, Hans-Helmut König, Corinna Engel and Gerhard Buchkremer
    Citation: Trials 2010 11:123
  32. Despite being preventable, suicide is a leading cause of death and a major global public health problem. For every death by suicide, many more suicide attempts are undertaken, and this presents as a critical r...

    Authors: Nicolas J. C. Stapelberg, Candice Bowman, Sabine Woerwag-Mehta, Sarah Walker, Angela Davies, Ian Hughes, Konrad Michel, Anthony R. Pisani, Heidy Van Engelen, Mia Delos, Tamara Hageman, Kim Fullerton-Smith, Ravikumar Krishnaiah, Sarah McDowell, Alison Cameron, Trudy-Lee Scales…
    Citation: Trials 2021 22:723
  33. The selection of appropriate outcomes or domains is crucial when designing clinical trials in order to compare directly the effects of different interventions in ways that minimize bias. If the findings are to...

    Authors: Paula R Williamson, Douglas G Altman, Jane M Blazeby, Mike Clarke, Declan Devane, Elizabeth Gargon and Peter Tugwell
    Citation: Trials 2012 13:132
  34. Obsessive-compulsive disorder (OCD) is a debilitating psychiatric disorder which affects up to 3% of children and adolescents. OCD in children and adolescents is generally treated with cognitive behavioural th...

    Authors: Markus Harboe Olsen, Julie Hagstrøm, Nicole Nadine Lønfeldt, Camilla Uhre, Valdemar Uhre, Linea Pretzmann, Sofie Heidenheim Christensen, Christine Thoustrup, Nicoline Løcke Jepsen Korsbjerg, Anna-Rosa Cecilie Mora-Jensen, Melanie Ritter, Janus Engstrøm, Jane Lindschou, Hartwig Roman Siebner, Frank Verhulst, Pia Jeppesen…
    Citation: Trials 2022 23:854
  35. Increasingly, it is argued that clinical trials struggle to recruit participants because they do not respond to key questions or study treatments that patients will be willing or able to use. This study explor...

    Authors: Magda Aguiar, Tracey-Lea Laba, Sarah Munro, Tiasha Burch, Jennifer Beckett, K. Julia Kaal, Nick Bansback, Marie Hudson and Mark Harrison
    Citation: Trials 2021 22:611
  36. This trial is an investigator-initiated single-center randomized clinical superiority trial of short-term (20 weeks) compared ... personality functioning, attachment, borderline symptoms, group alliance, and ment...

    Authors: Sophie Juul, Susanne Lunn, Stig Poulsen, Per Sørensen, Mehrak Salimi, Janus Christian Jakobsen, Anthony Bateman and Sebastian Simonsen
    Citation: Trials 2019 20:196

    The Update to this article has been published in Trials 2021 22:497

  37. Urologic chronic pelvic pain syndrome (UCPPS) encompasses several common, costly, diagnoses including interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome that are p...

    Authors: Jeffrey M. Lackner, James Jaccard, Brian M. Quigley, Tova S. Ablove, Teresa L. Danforth, Rebecca S. Firth, Gregory D. Gudleski, Susan S. Krasner, Christopher D. Radziwon, Alison M. Vargovich, J. Quentin Clemens and Bruce D. Naliboff
    Citation: Trials 2022 23:651
  38. There is a lack of high-quality evidence underpinning many contemporary clinical practice guidelines embedded in the healthcare systems, leading to treatment uncertainty and practice variation in most medical ...

    Authors: Tom Briffa, Tanya Symons, Nikolajs Zeps, Nicola Straiton, William Odita Tarnow-Mordi, John Simes, Ian A. Harris, Melinda Cruz, Steven A. Webb, Edward Litton, Alistair Nichol and Christopher M. Williams
    Citation: Trials 2021 22:620
  39. Depression is estimated to become the leading cause of disease burden globally by 2030. Despite existing efficacious treatments (both medical and psychotherapeutic), a large proportion of patients do not respo...

    Authors: Cezar Giosan, Oana Cobeanu, Cristina Mogoase, Vlad Muresan, Loretta S Malta, Katarzyna Wyka and Aurora Szentagotai
    Citation: Trials 2014 15:83
  40. This article provides a description of the rationale, design, and methods of a multisite clinical trial which evaluates the potential benefits of an evidence-based psychosocial treatment, STAIR Narrative Thera...

    Authors: Marylene Cloitre, Clare Henn-Haase, Judith L Herman, Christie Jackson, Nadine Kaslow, Constance Klein, Michaela Mendelsohn and Eva Petkova
    Citation: Trials 2014 15:197
  41. Psychotherapy is highly effective and widely acknowledged for treating various mental disorders. Nevertheless, in terms of methods for teaching effective psychotherapeutic approaches and competencies, there ha...

    Authors: Franziska Kühne, Peter Eric Heinze and Florian Weck
    Citation: Trials 2020 21:276
  42. Patient and public involvement is increasingly common in trials, but its quality remains variable in a lot of settings. Many key decisions in trials involve numbers, but patients are rarely involved in those d...

    Authors: Beatriz Goulao, Hanne Bruhn, Marion Campbell, Craig Ramsay and Katie Gillies
    Citation: Trials 2021 22:499
  43. Major depression is a common mental disorder that substantially impairs quality of life and has high societal costs. Although psychotherapies have proven to be effective antidepressant treatments, initial resp...

    Authors: Lotte HJM Lemmens, Arnoud Arntz, Frenk PML Peeters, Steven D Hollon, Anne Roefs and Marcus JH Huibers
    Citation: Trials 2011 12:150
  44. Psychodynamic psychotherapy is frequently applied in the treatment of social phobia. Nevertheless, there has been a lack of studies on the transfer of manualized treatments to routine psychodynamic practice. O...

    Authors: Jörg Wiltink, Christian Ruckes, Antje Haselbacher, Marco Canterino, Falk Leichsenring, Peter Joraschky, Frank Leweke, Karin Pöhlmann and Manfred E Beutel
    Citation: Trials 2011 12:142
  45. Treatment guidelines recommend behaviour therapy (BT) for patients with Tourette syndrome (TS) and chronic tic disorder (CTD). However, BT is rarely accessible due to limited availability of trained therapists...

    Authors: Per Andrén, Lorena Fernández de la Cruz, Kayoko Isomura, Fabian Lenhard, Charlotte L. Hall, E. Bethan Davies, Tara Murphy, Chris Hollis, Filipa Sampaio, Inna Feldman, Matteo Bottai, Eva Serlachius, Erik Andersson and David Mataix-Cols
    Citation: Trials 2021 22:669

    The Correction to this article has been published in Trials 2022 23:541

Annual Journal Metrics

  • 2022 Citation Impact
    2.5 - 2-year Impact Factor
    2.5 - 5-year Impact Factor
    0.827 - SNIP (Source Normalized Impact per Paper)
    0.814 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    129 days submission to accept (Median)

    2023 Usage 
    6,282,238 downloads
    5,569 Altmetric mentions